Mannkind (MNKD) Gross Profit Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 51.16% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 44.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.64% |
| Dec 31, 2025 | 16.38% |
| Sep 30, 2025 | 59.08% |
| Jun 30, 2025 | 165.24% |
| Mar 31, 2025 | 369.27% |
| Dec 31, 2024 | 76.68% |
| Sep 30, 2024 | 53.76% |
| Jun 30, 2024 | 52.39% |
| Mar 31, 2024 | 68.21% |
| Dec 31, 2023 | 74.33% |
| Sep 30, 2023 | 47.59% |
| Jun 30, 2023 | 128.65% |
| Mar 31, 2023 | 31.29% |
| Dec 31, 2022 | 76.24% |
| Sep 30, 2022 | 71.15% |
| Jun 30, 2022 | -1.51% |
| Mar 31, 2022 | -27.13% |
| Dec 31, 2021 | -56.78% |
| Sep 30, 2021 | 188.69% |
| Jun 30, 2021 | 160.60% |
| Mar 31, 2021 | 196.87% |
| Dec 31, 2020 | 218.50% |
| Sep 30, 2020 | 88.00% |
| Jun 30, 2020 | -5.96% |
| Mar 31, 2020 | 196.95% |
| Dec 31, 2019 | 11.50% |
| Sep 30, 2019 | -26.84% |
| Jun 30, 2019 | -0.67% |
| Mar 31, 2019 | 66.29% |
| Dec 31, 2018 | 30.55% |
| Sep 30, 2018 | -18.05% |
| Jun 30, 2018 | 40.45% |
| Mar 31, 2018 | 33.92% |